BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8404384)

  • 41. Imaging with indium111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen-producing cancer in patients with rising serum carcinoembryonic antigen levels and occult metastases.
    Patt YZ; Lamki LM; Shanken J; Jessup JM; Charnsangavej C; Ajani JA; Levin B; Merchant B; Halverson C; Murray JL
    J Clin Oncol; 1990 Jul; 8(7):1246-54. PubMed ID: 2193120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pilot study with the monoclonal antibody IOR-C5 as a potential agent of radioimmunoscintigraphy in colorectal cancer].
    Oliva JP; Pimentel G; Borrón M; Peralta R; Ortiz R; Oliver B; Díaz N; Sánchez I; Vázquez AM; Baum RP
    Rev Esp Med Nucl; 2001 Jun; 20(4):282-8. PubMed ID: 11940415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immunogammagraphy with anti-CEA and anti-TAG-72 monoclonal antibodies in the diagnosis of colorectal carcinoma].
    Muxí Pradas MA; Pons Pons F; Huguet Planella M; Novell Capilla F; García-Romero RH; Trias Folch M
    Med Clin (Barc); 1996 Nov; 107(16):601-7. PubMed ID: 9064391
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The value of immunoscintigraphy for the operative retreatment of colorectal cancer. Limitations of a new diagnostic method.
    Hölting T; Schlag P; Steinbächer M; Kretzschmar U; Georgi P; Herfarth C
    Cancer; 1989 Aug; 64(4):830-3. PubMed ID: 2743277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In-111 monoclonal antibody immunoscintigraphy of colorectal cancer.
    Lamki LM; Patt YZ; Murray JL
    Cancer Treat Res; 1990; 51():293-312. PubMed ID: 1977451
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical relevance of immunoscintigraphy with 99mTc-labelled anti-CEA antigen-binding fragments in the follow-up of patients with colorectal carcinoma. Assessment of surgical resectability with a combination of conventional imaging methods].
    Behr TM; Goldenberg DM; Scheele JR; Wolf FG; Becker W
    Dtsch Med Wochenschr; 1997 Apr; 122(15):463-70. PubMed ID: 9147937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.
    Delaloye B; Bischof-Delaloye A; Buchegger F; von Fliedner V; Grob JP; Volant JC; Pettavel J; Mach JP
    J Clin Invest; 1986 Jan; 77(1):301-11. PubMed ID: 3484753
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Operative probe scintimetry with indium and technetium for colorectal cancer.
    Kuhn JA; Nochumson J
    J Surg Oncol; 2007 Sep; 96(4):290-6. PubMed ID: 17879338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radioimmunoassisted follow-up and surgery vs traditional examinations and surgery after radical excision of colorectal cancer.
    Prati U; Roveda L; Cantoni A; Saponaro R; Bosi F; Sandolo R; Zonta A
    Anticancer Res; 1995; 15(3):1081-5. PubMed ID: 7645930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments.
    Goldenberg DM; Wlodkowski TJ; Sharkey RM; Silberstein EB; Serafini AN; Garty II; Van Heertum RL; Higginbotham-Ford EA; Kotler JA; Balasubramanian N
    J Nucl Med; 1993 Jan; 34(1):61-70. PubMed ID: 8418273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-CEA immunoscintigraphy might be more useful than computed tomography in the preoperative thoracic evaluation of lung cancer. A comparison between planar immunoscintigraphy, single photon emission computed tomography (SPECT), and computed tomography.
    Buccheri G; Biggi A; Ferrigno D; Leone A; Taviani M; Quaranta M
    Chest; 1993 Sep; 104(3):734-42. PubMed ID: 8365283
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunoscintigraphy in the surgical management of colorectal cancer.
    Galandiuk S
    J Nucl Med; 1993 Mar; 34(3 Suppl):541-4. PubMed ID: 8441054
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA102: experience of 20 cases].
    Murakami K; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Wada K; Sakuma S; Takagi H
    Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):119-27. PubMed ID: 8464409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of radioimmunoscintigraphy on the management of recurrent colorectal cancer.
    Lunniss PJ; Skinner S; Britton KE; Granowska M; Morris G; Northover JM
    Br J Surg; 1999 Feb; 86(2):244-9. PubMed ID: 10100796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Radioimmunoscintigraphy of colorectal tumors with 99m-Tc marked CEA antibodies. Indications and clinical value].
    Barzen G; Martini I; Schulz W; Löhde E; Böse-Landgraf J; Richter W; Langer M; Felix R
    Med Klin (Munich); 1992 Aug; 87(8):395-402. PubMed ID: 1406470
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Technology evaluation: CEA-Scan, Immunomedics Inc.
    Eccles SA
    Curr Opin Mol Ther; 1999 Dec; 1(6):737-44. PubMed ID: 19629871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancement of colorectal tumor targeting using a novel biparatopic monoclonal antibody against carcinoembryonic antigen in experimental radioimmunoguided surgery.
    Kim JC; Roh SA; Koo KH; Ryu JH; Hong HK; Oh SJ; Ryu JS; Kim HJ; Bodmer WF
    Int J Cancer; 2002 Feb; 97(4):542-7. PubMed ID: 11802220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pretargeted radioimmunoscintigraphy in patients with primary colorectal cancer using a bispecific anticarcinoembryonic antigen CEA X anti-di-diethylenetriaminepentaacetic acid F(ab')2 antibody.
    Aarts F; Boerman OC; Sharkey RM; Hendriks T; Chang CH; McBride WJ; Bleichrodt RP; Oyen WJ; Goldenberg DM
    Cancer; 2010 Feb; 116(4 Suppl):1111-7. PubMed ID: 20127959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of immunoscintigraphy and computerized tomography in identifying colorectal cancer: individual lesion analysis.
    Corbisiero RM; Yamauchi DM; Williams LE; Esteban JM; Odom-Maryon T; Beatty JD
    Cancer Res; 1991 Oct; 51(20):5704-11. PubMed ID: 1913688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Immunoscintigraphic follow-up studies with the 99m-Tc marked monoclonal anti-CEA antibody BW 431/26].
    Fritzsche H
    Acta Med Austriaca; 1990; 17(2-3):44-6. PubMed ID: 2220267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.